Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05802940 · ClinicalTrials.gov registry record · NA
Low Dose Aspirin Alerts in High-Risk Pregnancies
A NA study of Preeclampsia and Aspirin, sponsored by Geisinger Clinic.
- Active
- Registry status
- NA
- Development phase
- 839
- Enrollment target
- 1
- Study location
NCT05802940 is a NA study of Preeclampsia and Aspirin that is active but no longer recruiting, run by Geisinger Clinic. The registered enrollment target is 839 participants, below the 1,261-participant average among 39 other Preeclampsia trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05802940, a NA study of Preeclampsia and Aspirin, is active but no longer recruiting, sponsored by Geisinger Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 839 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize that the implementation of the EHR BPA tool will increase the healthcare provider's recommendation for low dose aspirin compared to current standard care.
Conditions Studied
Interventions
- BEHAVIORAL Electronic health record best practice alert
Study Locations (1)
Pennsylvania
- Geisinger Medical Center - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 839 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05802940
The ClinicalTrials.gov registry entry for NCT05802940 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 839 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,261-participant average among 39 other Preeclampsia trials with a reported enrollment target (33% lower). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Electronic health record best practice alert is the first listed.
NCT05802940 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05802940 about?
NCT05802940 is a clinical study titled "Low Dose Aspirin Alerts in High-Risk Pregnancies". The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize tha...
What is the current status of trial NCT05802940?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 839 participants. The study started on 2023-06-19. Estimated completion is 2026-02-28.
What conditions does trial NCT05802940 study?
This clinical trial studies the following conditions: Preeclampsia, Aspirin, Clinical Decision Support Systems, Economics, Behavioral.
What interventions are being tested in trial NCT05802940?
The interventions under investigation include: Electronic health record best practice alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT05802940?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05802940 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
Preeclampsia Educational Program Study (PrEPS)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.